Pfizer uses anti-counterfeiting packaging in Malaysia; Indian task force looks at drug manufacturing;

> Pfizer ($PFE) is using confirmation codes on packaging of drugs in Malaysia as an anti-counterfeiting move. Story

> Hemispherx Biopharma is testing its $8 million scaled-up manufacturing facility in Philadelphia where it will make its FDA approved drug for genital warts and other products in its pipeline. Release

> India's Department of Pharmaceuticals has created a task force to work on manufacturing standards by treatment category. News

> CDMO Cirrus Pharmaceuticals is adding a flexible suite at its facility in Research Triangle Park, NC. Item

> Fujifilm Holdings says it believes its influenza drug Avigan could be approved yet this year by global regulators as a treatment for patients with Ebola. Story

> Biocon's $160 million insulin plant in Malaysia is on schedule to open next year. Story